ObsEva S.A. OBSV
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 11.00M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.78
- Beta
- 0.67
- Short ratio
- 0.15
- Inst. own
- 13.42%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 23, 2023
- 50-d avg
- 0.135727
- 200-d avg
- 0.26982
- 1y target
- 12.00
YTD chart
Events in this range
- Mar 23, 2023Earnings: —; estimate 0; surprise —%
Signals (11)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Apr 3, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 10, 2023 | 3 years ago |
| SMA: Bearish | Mar 7, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 6, 2023 | 3 years ago |
| SMA: Bullish | Mar 3, 2023 | 3 years ago |
| RSI: Oversold | Feb 24, 2023 | 3 years ago |
| SMA: Bearish | Feb 21, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 8, 2023 | 3 years ago |
| RSI: Overbought | Jan 27, 2023 | 3 years ago |
| SMA: Bullish | Jan 5, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 3, 2023 | 3 years ago |
Key statistics
- Market cap
- 11.00M
- Enterprise value
- 8.92M
- Trailing P/E
- 0.00
- Forward P/E
- -0.78
- PEG ratio
- 0.00
- Price / sales
- 2.96
- Price / book
- 0.00
- EPS (TTM)
- -0.74
- Beta
- 0.67
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 3.71M
- Revenue growth
- -85.20%
- Free cash flow
- -22.65M
- Total cash
- 9.68M
- Total debt
- 9.27M
- Return on equity
- -373.98%
- Shares outstanding
- 108.02M
- Short % of float
- 0.78%
- 50-day average
- 0.135727
- 200-day average
- 0.26982
Analyst view
Consensus: hold
- Strong buy2
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Mar 23, 2023
Expected Mar 23, 2023. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 23, 2023 | Dec 1, 2022 | 0.00 | — | — | — |
| Dec 1, 2022 | Sep 1, 2022 | -0.14 | — | — | — |
| Aug 17, 2022 | Jun 1, 2022 | -0.22 | — | — | — |
| May 17, 2022 | Mar 1, 2022 | -0.25 | — | — | — |
| Mar 10, 2022 | Dec 1, 2021 | -0.22 | — | — | — |
| Nov 4, 2021 | Sep 1, 2021 | -0.22 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 30, 2022 | HC Wainwright & Co. | down | Buy | Neutral |
| Jun 3, 2022 | Cantor Fitzgerald | init | — | Overweight |
| Apr 26, 2022 | Canaccord Genuity | init | — | Buy |
| Mar 28, 2022 | Aegis Capital | init | — | Buy |
| Mar 28, 2022 | HC Wainwright & Co. | main | — | Buy |
| Nov 29, 2021 | HC Wainwright & Co. | main | — | Buy |
About ObsEva S.A.
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company is also involved in developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, which is in Phase II clinical trial as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist that is in Phase I clinical trial to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Switzerland
- Website
- obseva.com
News
- Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Earnings Scheduled For March 6, 2023
- Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
- Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
- Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
- Earnings Scheduled For November 14, 2022
Your note
Sign in to keep a note on OBSV — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| LOUMAYE ERNEST | Director | Purchase | Feb 27, 2023 | 6,000,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Sofinnova Investments, Inc. | 4.37% | 4,749,623 | 483.51K | Dec 30, 2022 |
| NEA Management Company, LLC | 4.22% | 4,586,563 | 466.91K | Dec 30, 2022 |
| Credit Suisse Ag/ | 1.61% | 1,750,573 | 178.21K | Dec 30, 2022 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.62% | 668,485 | 68.05K | Dec 30, 2022 |
| Pictet Asset Management SA | 0.33% | 363,772 | 37.03K | Dec 30, 2022 |
| Cutter & Co. Brokerage, Inc. | 0.19% | 201,200 | 20.48K | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.08% | 82,227 | 8.37K | Nov 29, 2022 |